ePlus inc. (PLUS) Market Cap & Valuation Ratios
ePlus inc. (PLUS) has a market cap of $2.5B, a trailing P/E of 20.0 and a price-to-sales ratio of 1.0, with earnings according to EquiReason's reading of its SEC filings.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
PLUSePlus inc.Follow PLUS — free
—
Price chart with a free account
- Market cap
- 2.5B
- P/E TTM
- 20.0
- Dividend yield
- 0.8%
- 52-week
- —
- Next earnings
- 10 Nov, in 17 days
Peers
software - application · nearest by market cap · trailing 12 months| Company | Mkt cap, $B | P/E | EV/Sales | EV/EBITDA | FCF yield | Rev. growth | Op. margin | ROIC |
|---|---|---|---|---|---|---|---|---|
| PLUS | 2.5 | 20.0 | 0.8 | 10.4 | 2.2% | +16% | 7% | 21% |
| PTRN | 2.9 | — | 0.8 | 41.6 | 3.7% | +44% | 1% | 11% |
| ASAN | 2.8 | — | 3.1 | — | 4.1% | +9% | -19% | — |
| KC | 2.5 | — | — | — | — | +31% | -8% | -8% |
| BLKB | 2.5 | 17.4 | 3.2 | 11.7 | 11.0% | +0.7% | 20% | 17% |
| VERX | 2.5 | — | 3.3 | 27.7 | 1.1% | +11% | -2% | -4% |
| NCNO | 2.4 | 74.7 | 4.2 | 29.3 | 5.4% | +9% | 8% | 3% |
| GRND | 2.4 | 27.4 | 5.4 | 17.7 | 6.0% | +32% | 30% | 32% |
| DBD | 2.3 | 22.8 | 0.8 | 8.1 | 9.0% | +5% | 6% | 11% |
| ADEA | 2.3 | 19.5 | 5.5 | 10.1 | 8.1% | +24% | 42% | 19% |
| AMPL | 2.2 | — | 5.4 | — | 1.2% | +18% | -25% | -86% |
| Median of these 10 | 22.8 | 3.3 | 17.7 | 5.4% | +15% | 4% | 11% |
P/E 20.0 vs. a peer median of 22.8; EV/Sales 0.8 vs. 3.3. PLUS's own P/E sits at the 81st percentile of its history.
Growth vs. price
each dot a company · hover or tap for valuesPTRN and ASAN and KC and VERX and AMPL have no P/E (earnings not positive) and are left out · hover or tap a dot for values.
ePlus inc. — questions
- What is ePlus inc.'s market cap?
- $2.5B.
- What is ePlus inc.'s P/E ratio?
- 20.0 on trailing twelve-month earnings to 2026-06-30.
- What is ePlus inc.'s price-to-sales ratio?
- 1.0.
Every figure on this page comes from ePlus inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.